Management of patients with hepatitis B who require immunosuppressive therapy
Open Access
- 19 November 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Gastroenterology & Hepatology
- Vol. 11 (4), 209-219
- https://doi.org/10.1038/nrgastro.2013.216
Abstract
No abstract availableThis publication has 94 references indexed in Scilit:
- Low Rates of Hepatitis B Virus Screening at the Onset of ChemotherapyJournal of Oncology Practice, 2012
- Changes of Hepatitis B Virus Serologic Status after Allogeneic Hematopoietic Stem Cell Transplantation and Impact of Donor Immunity on Hepatitis B VirusTransplantation and Cellular Therapy, 2011
- Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapyAnnals Of The Rheumatic Diseases, 2011
- Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reportsAnnals of Oncology, 2011
- Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapyBritish Journal of Cancer, 2011
- Resolved Hepatitis B Virus Infection Is Not Associated with Worse Outcome after Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2010
- Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCTBone Marrow Transplantation, 2010
- Hepatitis B Virus Reactivation following Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2009
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host diseaseBone Marrow Transplantation, 2002